Milestone Pharmaceuticals (MIST) Assets Average (2019 - 2026)

Milestone Pharmaceuticals (MIST) has reported Assets Average for 8 consecutive years, with $187.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets Average rose 243.41% year-over-year to $187.7 million; the trailing twelve-month figure through Jun 2026 stood at $187.7 million (up 243.41% YoY), and the FY2025 full-year result was $94.5 million, up 25.43% from the prior year.
• Assets Average rose to $187.7 million in Q2 2026 per MIST's latest filing, from $153.6 million in the prior quarter.
• Across five years, Assets Average topped out at $187.7 million in Q2 2026 and bottomed at $54.7 million in Q2 2025.
• Historically, Assets Average has averaged $95.9 million across 5 years, with a median of $90.3 million in 2022.
• The sharpest annual moves came in 2025 and 2026: Assets Average plunged 40.99% in 2025, then soared 243.41% in 2026.
• Over 5 years, Assets Average stood at $80.1 million in 2022, then rose by 1.3% to $81.2 million in 2023, then fell by 2.55% to $79.1 million in 2024, then gained by 27.25% to $100.7 million in 2025, then soared by 86.46% to $187.7 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $187.7 million, $153.6 million, and $100.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.